GM salmon and the FDA: 10 takeaways

James Wright

Controversial AquAdvantage approved, could hit the market as soon as 2017 AquAdvantage salmon. Photo courtesy of AquaBounty Technologies. The U.S. Food and Drug Administration (FDA) announced last Thursday that it had finally approved AquaBounty’s new animal drug application for the production, sale and consumption of its fast-growing and genetically modified (GM) AquAdvantage salmon. It’s a…

Global Aquaculture Advocate articles are free to read.
Please log in or create your own free profile.

  • James Wright

    James Wright

    Editorial Manager
    Global Aquaculture Alliance
    Portsmouth, NH, USA